Piramal Pharma (NSE:PPLPHARMA) Total Stockholders Equity : ₹79,114 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Total Stockholders Equity?

Piramal Pharma's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ₹79,114 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Piramal Pharma's Book Value per Share for the quarter that ended in Mar. 2024 was ₹60.02. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Piramal Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.60.

Piramal Pharma Total Stockholders Equity Historical Data

The historical data trend for Piramal Pharma's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Total Stockholders Equity Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Stockholders Equity

41,006.20

66,966.00

67,735.00

79,113.70

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial							67,735.00	-	77,578.60	-	79,113.70

Piramal Pharma (NSE:PPLPHARMA) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Piramal Pharma's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(79113.7	-	0)	/	1318.02
	=	60.02

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Piramal Pharma's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(21084.2	+	26017.4)	/	79113.7
	=	0.60

Piramal Pharma Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines